Insider Transactions in Q1 2024 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,005
-1.54%
|
$14,035
$7.8 P/Share
|
|
Mar 01
2024
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,540
-1.61%
|
$36,320
$8.05 P/Share
|
|
Mar 01
2024
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,684
-5.05%
|
$93,472
$8.05 P/Share
|
|
Mar 01
2024
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+36.41%
|
-
|
|
Mar 01
2024
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,474
-4.52%
|
$19,792
$8.05 P/Share
|
|
Mar 01
2024
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,315
-2.67%
|
$26,520
$8.05 P/Share
|
|
Mar 01
2024
|
Daniel Le Sueur Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+28.66%
|
-
|
|
Mar 01
2024
|
Daniel Le Sueur Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,279
-3.05%
|
$26,232
$8.05 P/Share
|
|
Mar 01
2024
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,439
-2.57%
|
$27,512
$8.05 P/Share
|
|
Mar 01
2024
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,973
-0.42%
|
$39,784
$8.05 P/Share
|
|
Feb 27
2024
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
26,200
+2.19%
|
$183,400
$7.81 P/Share
|
|
Feb 20
2024
|
Bryan Truman Hunt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,111
+4.58%
|
-
|
|
Feb 20
2024
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,778
+4.83%
|
-
|
|
Feb 20
2024
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
68,889
+18.1%
|
-
|
|
Feb 20
2024
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
79,444
+20.98%
|
-
|
|
Feb 20
2024
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,334
+14.77%
|
-
|
|
Feb 20
2024
|
Daniel D. Burton Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+17.9%
|
-
|
|
Feb 15
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,262
-4.79%
|
$29,358
$9.77 P/Share
|
|
Jan 16
2024
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,163
-4.44%
|
$31,630
$10.83 P/Share
|